Diversity in Pharma: The Impact of COVID-19 on DE&I
FREE Webinar | Thursday, 23 June 2022 - 3:00 pm
____________________________________________________________________________________________________
Meet the panel:
Andrés López Castaño, Vaccine Therapeutic Area Lead, Global LGBTQI+ ERG Lead, MSD Switzerland
Andrés has around 17 years’ experience in Clinical Research. His experience expands from site coordination, clinical operations, clinical trial metrics through clinical data management. For the past 10 years at MSD, he was part of the leadership team in Clinical Data Operations and member of the foundational team that set a new team in Zurich focused on Vaccine Clinical Data Operations. Andrés is also a seasoned Diversity & Inclusion lead and has participated as speaker in this area in many opportunities. He currently leads D&I for the Europe LGBT+ Employee Resource Network, the Zurich office as well as the Global Data Management organization at MSD. In these spaces, he designed, rolled out and implement several D&I initiatives, locally, regionally and globally. Andrés was recognized in 2021 by OUTstanding as 100 LGBT+ Future Leaders List supported by Yahoo Finance.
Tricia Lucas-Clarke, Early Talent Recruitment Inclusion and Diversity Manager, GSK
Tricia is an early talent recruitment inclusion and diversity manager, diverse reverse mentor and race champion who is committed to improving diversity, equity and inclusion in society. She is also a contributing writer and podcaster for female-focussed projects as well as facilitating discussions for people to discuss ethnicity and gender, so understands why individuals, particularly women, still struggle to speak up about their achievements and feel unheard when they do.
Noor Shaker, Senior Vice President and General Manager, X-Chem
Noor is a biotech entrepreneur and recognized healthcare innovator. Prior to Glamorous AI (acquired by X-Chem in October 2021), she was an assistant professor at Aalborg University. Noor is passionate about data and artificial intelligence (AI) and is on a mission to cure disease by pushing the boundaries for what is possible with AI. She has a record of achievements in AI, including numerous papers published in the field and its application to drug discovery, as well as holding a number of AI patents. She sits on AI and diversity advisory boards for prestigious organizations and universities and is a recognized healthcare leader — she was one of the 2018 winners of Innovators Under 35 Europe from MIT Technology Review and named one of BBC’s 100 Women of 2019.